E2. The Pathophysiology of Long Covid ft. Prof. Danny Altmann. A Certified CPD Podcast for Healthcare Professionals. Please Log In to claim your CPD credits toward your medical license. (Canada & Worldwide) Join us for insightful discussions on Long COVID with Professor Danny Altmann, delving into its pathophysiology, persistent viral reservoirs, organ damage implications, and
with further research existing treatments targeting the eradication/reduction of these type of autoantibodies for Long COVID could be used and biomarkers (blood tests to show the presence of Long COVID) could be developed to identify these autoantibodies in Long Haulers who have these types of neurological symptoms, particularly those with chronic pain.
There over 200 widely varying symptoms associated with Long Covid. Why is this? Find the answers in our Accredited Podcast with Dr Amy Proal, Microbiologist.
Gastrointestinal issues in Long COVID often include symptoms such as diarrhea, abdominal pain, and irritable bowel syndrome. These issues are linked to disruptions in the gut microbiome and alterations in serum metabolites
This study focuses on COVID-19's long-term effects include debilitating "long COVID" symptoms, impacting millions and highlighting similarities with other post-acute infectious syndromes like ME/CFS, necessitating further research and public health measures
A research paper has revealed that children and adolescents who have COVID-19 were at a higher risk of developing major kidney problems post COVID infection, even if they had no prior kidney disease...
Kayli Jamieson (she/her) has been a longhauler since December 2021 and has been on and off medical leave from work and school since then. Nowadays, she works from home as a Long COVID researcher for PIPPS and is slowly writing a Master’s Thesis on Long COVID and biopolitics. When she’s not resting, she enjoys singing and playing
Since 2020, Chimére L. Sweeney has been a tireless advocate for the inclusion of Black women with Long Covid in discussions and initiatives aimed at amplifying their distinct narratives, aiding in their condition management and treatment, and empowering them as genuine stakeholders in advocacy and research efforts.
Finding help can be difficult. We hope to remove a barrier by listing Long Covid Practioners for various Long Covid symptoms.
This is the first Paxlovid trial out looking at whether Paxlovid would work for Long COVID treatment with the thinking that if the theory of a viral reservoir, or viral persistence is causing the illness then a drug that reduces the virus should help reduce the symptoms. The results of this trial have been talked
